AUG 13, 2019 9:21 AM PDT

Blood-Brain Barrier Impairment and Its Role in Alzheimer's Disease

WRITTEN BY: Dena Aruta

In healthy people, the blood-brain barrier (BBB), which is formed by brain endothelial cells, strictly controls the entrance of harmful materials into the brain and prevents anything toxic from crossing over. In addition, it regulates the clearance of β‐amyloid (Aβ) peptides, which are found in the brains of Alzheimer's patients. Impairment of the BBB is an important factor in many neurological diseases including Alzheimer's disease (AD). The breakdown of the BBB is present even before symptoms of cognitive decline and pathological changes are seen. 

Since the dysfunction of the BBB is believed to be a key component in the development of AD, there is enormous interest in creating cell-based models that imitate the same changes in the BBB seen in AD. Classic in vitro cell models have given greater insight into the pathological processes involved in AD and have helped in the discovery of new drugs to treat it. However, these models are of limited use because they lack many features of the BBB. Researchers at MIT have developed a "physiologically relevant 3D human neural cell culture microfluidic model" to study the role that blood vessels in the cerebrum play in AD.

The researchers created a 3D AD model that can perform numerous functions the in vitro BBB models cannot. These include: (1) a 3D microenvironment for cells to quantitatively evaluate BBB permeability, (2) integration of multiple steps into one experimental platform, (3) enhances quality of imaging studies and reduces reagent and tissue sample sizes, (4) the method supports different culture conditions and maturation periods of ReN cells (neural precursor cells) and the brain endothelial cells, and (5) provides an area for gradual accumulation of Aβs by allowing AD cells to continuously release Aβ, which slowly collects in and diffuses into the extracellular matrix.

"We were able to show clearly in this model that the amyloid-beta secreted by Alzheimer's disease cells can actually impair barrier function, and once that is impaired, factors are secreted into the brain tissue that can have adverse effects on neuron health," says Roger Kamm, the Cecil and Ida Green Distinguished Professor of Mechanical and Biological Engineering at MIT.

In order to demonstrate the impact a dysfunctional BBB has on AD pathogenesis, Shin and colleagues introduced the neurotoxic molecule, thrombin, the major enzyme involved in the coagulation system, into the 3D Ad model. It was able to pass through the BBB and caused neuronal death, but when etodolac, an NSAID drug, was applied to the membranes, thrombin was prevented from crossing the BBB. Another drug, beclomethasone, was also tried but did not decrease the BBB permeability as etodolac did.

"We're starting to use this platform to screen for drugs that have come out of very simple single cell screens that we now need to validate in a more complex system," Kamm says. "This approach could offer a new potential form of Alzheimer's treatment, especially given the fact that so few treatments have been demonstrated to be effective."

The original paper was published in Advanced Science on August 12, 2019.

 

About the Author
  • After earning my Bachelor of Science degree in biology/chemistry from Virginia Polytechnic Institute and State University (aka Va. Tech), I went on to complete clinical rotations in laboratory medicine at Roanoke Memorial Hospital. I spent the next 21 years working in healthcare as a clinical microbiologist. In 2015, I combined my fascination with medicine and passion for writing into a freelance career, and I haven't looked back. Even though my expertise is in microbiology and infectious diseases, I'm adept at writing about any medical topic. Being a freelance writer allows me to pursue a career where I can work at home with my two feline assistants, Luke and Grace. I'm a firm supporter of animal rights and volunteer for a local rescue during my free time. 
You May Also Like
OCT 01, 2020
Drug Discovery & Development
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
OCT 01, 2020
HPV Vaccine Protects Against Cervical Cancer, Large Study Finds
It has been known for some time that the HPV vaccine protects against human papillomavirus infection, genital warts, and ...
OCT 06, 2020
Microbiology
Scarlet Fever 'Superclones' Pose Rising Public Health Threat
OCT 06, 2020
Scarlet Fever 'Superclones' Pose Rising Public Health Threat
More than 100 years ago, the world faced waves of scarlet fever epidemics; between around 1820 and 1880 there were sever ...
OCT 21, 2020
Immunology
CNS's immune cells - Microglia are involved in the exacerbation of MS
OCT 21, 2020
CNS's immune cells - Microglia are involved in the exacerbation of MS
Multiple sclerosis (MS) is one of the most progressive autoimmune diseases that affect the central nervous system where ...
OCT 21, 2020
Microbiology
The First Treatment for Ebola is Approved by FDA
OCT 21, 2020
The First Treatment for Ebola is Approved by FDA
Ebola virus can pass from animals to humans, and between people. Rarely, it causes outbreaks but when it does, they can ...
OCT 28, 2020
Cancer
Protecting the Head and Neck from Off Target Radiation
OCT 28, 2020
Protecting the Head and Neck from Off Target Radiation
Radiotherapy alone or with chemotherapy is the go-to treatment for head and neck cancers. Unfortunately, head and neck t ...
OCT 26, 2020
Genetics & Genomics
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
OCT 26, 2020
Does a 'Mismatch' Between Diet and Biology Cause Poor Health?
People that eat a 'paleo' diet operate under the idea that we should be eating more like our ancestors, and that metabol ...
Loading Comments...